Mankind Pharma Ltd.
Issue Open Date 25-Apr-23  
Issue Closing Date 27-Apr-23  
Application Money 100  
Allotment Money  
Price Band () 1026 - 1080  
Minimum Bid Quantity. 13  
Issue Size (Shares) 40058844  
Market Lot 1  
Objective

(i) carry out the Offer for Sale of 40,058,844 Equity Shares by the Selling Shareholders aggregating to ? [?] million.(ii) achieve the benefits of listing the Equity Shares on the Stock Exchanges.

Business Description

We are India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for the Financial Year 2022 (Source: IQVIA Dataset, IQVIA TSA MAT March 2022 Dataset for India (For FY20-22)). We are engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as we...

Promoter's Holding
Total Share Capital   316464857  
Offered to Public   40058844  
Promoter's Holding (Pre-Issue)   79  
Promoter's Holding (Post-Issue)   76.5  
Address
Address :208
Okhla Industrial Estate
Phase - 111
City :New Delhi, State :Delhi Pincode :110020 Phone :011-46846700 Email : investors@mankindpharma.com Website : www.mankindpharma.com
Registrar
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B
Plot 31-32
Gachibowli
Financial District
Nanakramguda
Hyderabad
Listed at
BSE, NSE
Lead Manager
Axis Capital Ltd.
IIFL Securities Ltd.
Jefferies India Pvt Ltd.
JP Morgan India Pvt Ltd
Kotak Mahindra Capital Co Ltd
Promoters
Prem Sheetal Family Trust
Rajeev Juneja
Rajeev Juneja Family Trust
Ramesh Juneja
Ramesh Juneja Family Trust
Sheetal Arora

© 2019. MSE Financial Services Ltd. All Rights Reserved

Developed & Content Powered by  Accord Fintech Pvt. Ltd.